Leiner Looks To Distribute U.S. OTCs In December, Production Start Unknown
This article was originally published in The Tan Sheet
Executive Summary
Leiner Health Products could restart distributing some of its OTC products as early as December, but the resumption of its U.S. OTC manufacturing operations is still undetermined, the firm said Nov. 9
You may also be interested in...
Leiner Closing Plant, Changes Executives To Prepare For Re-entering Market
Leiner Health Products is closing its Wilson, N.C., over-the-counter manufacturing facility to reduce operating expenses as its re-entry to the OTC market is delayed, the firm states in recent filings with the Securities and Exchange Commission
Leiner Plans Suit Against Dr. Reddy’s, Expects Delay Restarting OTC Business
Leiner Health Products' restart of its U.S. OTC operations could be delayed due to the loss of an exclusive ingredient supply contract with Dr. Reddy's Laboratories, the Carson, Calif.-based firm says
Leiner Suspends U.S. OTC Operations, Expects Perrigo To Meet Demand
Leiner Health Products expects to lose business to competing private-labeler Perrigo following the voluntary suspension of its U.S. OTC operations